Log in
Enquire now
‌

US Patent 9839635 Lanthionine synthetase C-like 2-based therapeutics

Patent 9839635 was granted and assigned to Landos Biopharma on December, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Patent abstract

Provided are compounds that target the lanthionine synthetase C-like protein 2 pathway. The compounds can be used to treat a number of conditions, including infectious disease, autoimmune disease, diabetes, and a chronic inflammatory disease.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9839635 Lanthionine synthetase C-like 2-based therapeutics

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.